Mundo, Rechel E.
HRN: 21-18-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2022
METRONIDAZOLE 500MG (TAB)
05/15/2022
05/22/2022
PO
500mg
Q8H
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes